These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 11099154)
1. Nasal secretion in ragweed-sensitized dogs: effect of leukotriene synthesis inhibition. Cardell LO; Agustí C; Nadel JA Acta Otolaryngol; 2000 Sep; 120(6):757-60. PubMed ID: 11099154 [TBL] [Abstract][Full Text] [Related]
2. Reduced allergen-induced nasal congestion and leukotriene synthesis with an orally active 5-lipoxygenase inhibitor. Knapp HR N Engl J Med; 1990 Dec; 323(25):1745-8. PubMed ID: 1701029 [TBL] [Abstract][Full Text] [Related]
3. LTB(4)-induced nasal gland serous cell secretion mediated by neutrophil elastase. Cardell LO; Agustí C; Takeyama K; Stjärne P; Nadel JA Am J Respir Crit Care Med; 1999 Aug; 160(2):411-4. PubMed ID: 10430706 [TBL] [Abstract][Full Text] [Related]
4. Nitric oxide-dependent neutrophil recruitment: role in nasal secretion. Cardell LO; Agustí C; Nadel JA Clin Exp Allergy; 2000 Dec; 30(12):1799-803. PubMed ID: 11122220 [TBL] [Abstract][Full Text] [Related]
5. A-78773: a selective, potent 5-lipoxygenase inhibitor. Bell RL; Brooks DW; Young PR; Lanni C; Stewart AO; Bouska J; Malo PE; Carter GW J Lipid Mediat; 1993; 6(1-3):259-64. PubMed ID: 8395248 [TBL] [Abstract][Full Text] [Related]
6. Canine model of nasal congestion and allergic rhinitis. Tiniakov RL; Tiniakova OP; McLeod RL; Hey JA; Yeates DB J Appl Physiol (1985); 2003 May; 94(5):1821-8. PubMed ID: 12547842 [TBL] [Abstract][Full Text] [Related]
7. Allergen-stimulated leukotriene B4 and interleukin-8 levels in patients with asthma and allergic rhinitis-modulation by a lipid pathway inhibitor. Frieri M; Therattil JM; Zitt M; Bouboulis D; Wang SF; Lark G; Schaefer PA; Sansone G Ann Allergy Asthma Immunol; 1998 Oct; 81(4):331-6. PubMed ID: 9809497 [TBL] [Abstract][Full Text] [Related]
8. Superoxide dismutase failed to attenuate allergen-induced nasal congestion in ragweed-sensitized dogs. Skorohod N; Yeates DB J Appl Physiol (1985); 2005 Apr; 98(4):1478-86. PubMed ID: 15608092 [TBL] [Abstract][Full Text] [Related]
9. Nasal inflammatory mediator release in ragweed allergic rhinitis: correlation with cellular influx into nasal secretions. Georgitis JW; Stone BD; Gottschlich G Int Arch Allergy Appl Immunol; 1991; 96(3):231-7. PubMed ID: 1666629 [TBL] [Abstract][Full Text] [Related]
10. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Pullerits T; Praks L; Skoogh BE; Ani R; Lötvall J Am J Respir Crit Care Med; 1999 Jun; 159(6):1814-8. PubMed ID: 10351924 [TBL] [Abstract][Full Text] [Related]
11. Leukotrienes in rhinitis. Howarth PH Am J Respir Crit Care Med; 2000 Feb; 161(2 Pt 2):S133-6. PubMed ID: 10673242 [No Abstract] [Full Text] [Related]
12. Important roles of tachykinins in the development of allergic nasal hyperresponsiveness in guinea-pigs. Nabe T; Tsuzuike N; Ohtani Y; Mizutani N; Watanabe S; Fujii M; Yoshimura M; Nagasawa M; Kohno S Clin Exp Allergy; 2009 Jan; 39(1):138-46. PubMed ID: 18778270 [TBL] [Abstract][Full Text] [Related]
13. Leukotrienes: their role in the treatment of asthma and seasonal allergic rhinitis. Banasiak NC; Meadows-Oliver M Pediatr Nurs; 2005; 31(1):35-8. PubMed ID: 15794321 [No Abstract] [Full Text] [Related]
14. Allergen-induced release of sulphidopeptide leukotrienes (SRS-A) and LTB4 in allergic rhinitis. Shaw RJ; Fitzharris P; Cromwell O; Wardlaw AJ; Kay AB Allergy; 1985 Jan; 40(1):1-6. PubMed ID: 2983580 [TBL] [Abstract][Full Text] [Related]
15. Involvement of leukotriene B4 in itching in a mouse model of ocular allergy. Andoh T; Sakai K; Urashima M; Kitazawa K; Honma A; Kuraishi Y Exp Eye Res; 2012 May; 98():97-103. PubMed ID: 22504036 [TBL] [Abstract][Full Text] [Related]
16. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages. Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930 [TBL] [Abstract][Full Text] [Related]
17. Involvement of thromboxane A2 and peptide leukotrienes in early and late phase nasal blockage in a guinea pig model of allergic rhinitis. Yamasaki M; Mizutani N; Sasaki K; Nabe T; Matsumoto T; Ashida Y; Kohno S Inflamm Res; 2001 Sep; 50(9):466-73. PubMed ID: 11603852 [TBL] [Abstract][Full Text] [Related]
18. Zileuton prevents the activation of the leukotriene pathway and reduces sebaceous lipogenesis. Zouboulis CC; Seltmann H; Alestas T Exp Dermatol; 2010 Feb; 19(2):148-50. PubMed ID: 19645854 [TBL] [Abstract][Full Text] [Related]
19. Absence of nasal priming as measured by rhinitis symptom scores of ragweed allergic patients during seasonal exposure to ragweed pollen. Grammer L; Wiggins C; Shaughnessy MA; Chmiel J Allergy Proc; 1990; 11(5):243-6. PubMed ID: 2258045 [TBL] [Abstract][Full Text] [Related]
20. Benefits from adding the 5-lipoxygenase inhibitor zileuton to conventional therapy in aspirin-intolerant asthmatics. Dahlén B; Nizankowska E; Szczeklik A; Zetterström O; Bochenek G; Kumlin M; Mastalerz L; Pinis G; Swanson LJ; Boodhoo TI; Wright S; Dubé LM; Dahlén SE Am J Respir Crit Care Med; 1998 Apr; 157(4 Pt 1):1187-94. PubMed ID: 9563738 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]